Nuvilex's (NVLX) Dr. Mark Rabe Talks Medical Marijuana, Legalization and Cell-in-a-Box

NEW YORK, NY--(Marketwired - Feb 12, 2014) - Nuvilex, Inc. ( OTCQB : NVLX ) is a biotechnology company that's focused on getting into late phase clinical trials for the treatment of advanced, inoperable pancreatic cancer, but it also expects to be a major player in the medical marijuana arena. And, to that end, last December, Nuvilex landed a leading figure in the medical marijuana field in Dr. Mark L. Rabe. Dr. Rabe was appointed as the Chairman of the Scientific Advisory Board of Medical Marijuana Sciences (MMS), the wholly-owned subsidiary Nuvilex formed to house its work in the Cannabis industry.
http://finance.yahoo.com/news/nuvilexs-dr-mar...00939.html

(0)